Skip Navigation


The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients.

Bookmark | Print | E-Mail

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic e-mail notifications as soon as a clinical trial is posted in the medical category you're interested in.






Home » Drug Information » FDA-Approved Drugs » 1999
Medical Areas: Gastroenterology

View By: Year Company Therapeutic Areas Drug Names 

Drug Information

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Drug Name: Prevpac

Company: TAP Pharmaceuticals
Approval Status: Approved February 1999
Treatment Area: Gastroenterology

General Information

Prevpac (lansoprazole, clarithromycin and amoxicillin), Rx, has been approved for the eradication of H. pylori to reduce the risk of duodenal ulcer recurrence. This efficacy supplement changed the duration of treatment with lansoprazole from 14 to 10 days and included recent minor changes to the clarithromycin labeling.


Jobson Medical Information

Copyright © 1995-2010 Jobson Medical Information LLC.


Designed by Piehead Productions LLC.